Protalix BioTherapeutics, Inc. - COM (PLX)

Historical Holders from Q4 2019 to Q3 2025

Symbol
PLX on NYSE
Type / Class
Equity / COM
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
13,927,352
Holdings value
$30,914,125
% of all portfolios
0%
Number of holders
76
Number of buys
32
Number of sells
-24
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of Protalix BioTherapeutics, Inc. - COM (PLX)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 13,927,352 $30,914,125 +$4,618,112 $2.22 76
2025 Q2 11,908,531 $17,628,861 +$1,905,095 $1.48 62
2025 Q1 8,186,092 $20,953,817 +$9,615,818 $2.56 63
2024 Q4 4,467,337 $8,398,680 +$2,201,784 $1.88 46
2024 Q3 3,383,529 $3,451,053 -$2,253,845 $1.02 43
2024 Q2 5,625,789 $6,582,396 -$4,774,740 $1.17 64
2024 Q1 9,445,037 $11,900,614 -$696,249 $1.26 61
2023 Q4 9,848,515 $17,531,878 +$1,241,481 $1.78 65
2023 Q3 9,166,276 $15,209,597 -$97,896 $1.66 61
2023 Q2 8,974,519 $17,902,094 +$11,998,091 $2 66
2023 Q1 2,937,638 $6,146,705 +$447,739 $2.1 34
2022 Q4 3,567,822 $4,870,646 +$111,553 $1.37 26
2022 Q3 3,548,189 $3,696,081 +$2,398,630 $1.04 26
2022 Q2 1,193,025 $1,298,298 +$25,721 $1.09 27
2022 Q1 1,217,014 $1,287,936 -$1,765,451 $1.06 28
2021 Q4 2,921,778 $2,436,675 -$1,654,962 $0.8317 24
2021 Q3 4,412,957 $5,908,463 +$92,750 $1.33 32
2021 Q2 4,315,299 $8,240,101 -$19,328,651 $1.91 31
2021 Q1 8,821,889 $39,349,366 +$21,195,496 $4.46 36
2020 Q4 4,087,703 $14,838,993 -$3,209,332 $3.63 22
2020 Q3 4,761,719 $18,443,257 -$1,925,407 $3.87 23
2020 Q2 5,260,461 $19,818,169 -$2,815,871 $3.79 26
2020 Q1 5,996,154 $14,097,585 +$12,574,926 $2.35 14
2019 Q4 645,294 $2,114,608 +$2,114,608 $3.28 8